Inventor · disambiguated record
Peter Jones
Also filed as: JONES PETER · JONES PETER R H
7 granted patents·10 pending applications·228 citations·filing 2002–2023
84Inventor score
Top patents by PatentIndex Score
17 records- 0197US7348427B2Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2004·Granted Mar 25, 2008·87 cites·5 claims
- 0295US6777425B2Isoquinoline compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Aug 17, 2004·132 cites·23 claims
- 0391US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0489US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 0579US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 0668US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0766US2011178074A1Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0866US2008200465A1Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0963US7265129B2Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2003·Granted Sep 4, 2007·1 cites·24 claims
- 1060US2008090816A1Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1154US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 1253US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1353US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1453US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1552US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1651US2003236198A1Antipathogenic benzamide compoundsGENESOFT INC·Filed 2002·Application pending·0 cites
- 1739US2019079092A1Method of Diagnosing Cancer by Determining the Level of One or More Volatile Organic CompoundsMDB DIAGNOSIS GROUP LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →